{"groups":[{"description":"* Rituximab 375 mg/m2 IV day1\n* Cladribine 4 mg/m2 IV over 2 hours days 1-5\n* Bortezomib 1.3 mg/m2 IV days 1 and 4\n* Repeat every 28 days for a maximum of 6 cycles\n\nrituximab: 375 mg/m2 IV Day 1. Repeat every 28 days for a maximum of 6 cycles.\n\nbortezomib: 1.3 mg/m2 IV Days 1 and 4. Repeat every 28 days for a maximum of 6 cycles.\n\ncladribine: 4 mg/m2 IV over 2 hours Days 1-5. Repeat every 28 days for a maximum of 6 cycles.","id":"FG000","title":"VCR (Velcade, Cladribine and Rituximab)"}],"periods":[{"milestones":[{"achievements":[{"groupId":"FG000","numSubjects":"24"}],"type":"STARTED"},{"achievements":[{"groupId":"FG000","numSubjects":"24"}],"type":"COMPLETED"},{"achievements":[{"groupId":"FG000","numSubjects":"0"}],"type":"NOT COMPLETED"}],"title":"Overall Study"}]}